CHARACTERISTICS AND CARE PATTERNS OF REAL-WORLD NON-ALCOHOLIC STEATOHEPATITIS (NASH) PATIENTS WITH AND WITHOUT LIVER BIOPSY

被引：0
|
作者：
Esposito, Daina [1 ]
Titievsky, Lina [2 ]
Dui, Simo [3 ]
Patel, Yuval [4 ]
Wong, Bruce [2 ]
Capozza, Thomas [2 ]
Ness, Erik [2 ]
Gallagher, Kerrin [3 ]
Jamal-Allial, Aziza [3 ]
Nguyen, Mindie H. [5 ]
机构：
[1] Pharmacotherapy Outcomes Res Ctr, Salt Lake City, UT USA
[2] Intercept Pharmaceut Inc, New York, NY USA
[3] Healthcore Inc, Wilmington, DE USA
[4] Duke Univ, Durham, NC 27706 USA
[5] Stamford Univ, Med Ctr, Gastroenterol & Hepatol, Stamford, CT USA
来源：
HEPATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1576
引用
收藏
页码：959 / 960
页数：2
相关论文
共 50 条
  • [11] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment
    Bugianesi, E
    Marzocchi, R
    Villanova, N
    Marchesini, G
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1105 - 1116
  • [12] COSTS AND HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH LEAN NON-ALCOHOLIC STEATOHEPATITIS (NASH) USING REAL-WORLD DATA (RWD)
    Tapper, E. B.
    Bonafede, M.
    Fishman, J.
    Dodge, S.
    Miller, K.
    Lewandowski, D.
    Bogdanov, A.
    VALUE IN HEALTH, 2022, 25 (12) : S45 - S45
  • [13] The burden of non-alcoholic steatohepatitis (NASH) among patients from Europe: A real-world patient-reported outcomes study
    Balp, Maria-Magdalena
    Krieger, Nancy
    Przybysz, Raymond
    Way, Nate
    Cai, Jennifer
    Zappe, Dion
    McKenna, Sarah Jane
    Wall, Garth
    Janssens, Nico
    Tapper, Elliot
    JHEP REPORTS, 2019, 1 (03) : 154 - 161
  • [14] LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC STEATOHEPATITIS (NASH) COMPARED TO NON-NASH PATIENTS
    Sadler, Erin
    Mehta, Neil
    Bhat, Mamatha
    Ghanekar, Anand
    Greig, Paul
    Grant, David
    Yao, Francis
    Sapisochin, Gonzalo
    TRANSPLANT INTERNATIONAL, 2017, 30 : 93 - 93
  • [15] Recurrence of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Following Liver Transplantation for NASH Cirrhosis
    Matsuoka, Lea
    Slaughter, James
    Campbell, Kathyrn
    Kerr, Ashlie
    Hamel, Stephanie
    Garza, Carissa
    Chotai, Pranit
    Alexopoulos, Sophoclis
    Scanga, Andrew
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 15 - 15
  • [16] Non-alcoholic steatohepatitis (NASH) in patients with chronic hepatitis
    Perez-Carreras, M
    Castellano, G
    Rivas, E
    Colina, F
    Alvarez, V
    Tomas, E
    Fuertes, A
    Solis-Herruzo, JA
    HEPATOLOGY, 2002, 36 (04) : 726A - 726A
  • [17] NASH (Non-Alcoholic Steatohepatitis): Fatty Liver or Fatal Liver Disease?
    Roeb, E.
    ZENTRALBLATT FUR CHIRURGIE, 2014, 139 (02): : 168 - 174
  • [18] Liver stiffness measurement using transient elastography in patients with non-alcoholic fatty liver (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Miette, Veronique
    Fournier, Celine
    Adara, Linda
    Sandrin, Laurent
    2007 IEEE ULTRASONICS SYMPOSIUM PROCEEDINGS, VOLS 1-6, 2007, : 1333 - 1336
  • [19] Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution
    Oldham, Stephanie
    Rivera, Christian
    Boland, Michelle L.
    Trevaskis, James L.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2019, (146):
  • [20] Non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) - A growing epidemic
    South, K
    GASTROENTEROLOGY NURSING, 2006, 29 (02) : 169 - 169
12345